This episode reviews a validation study of a single-well multiplex ddPCR assay that quantifies TPSAB1 α- and β-tryptase copy numbers to diagnose hereditary alpha tryptasemia (HαT) and defines an optimal basal serum tryptase (BST) cutoff for clinical screening.
0:19Welcome to Base by Base, the papercast that brings genomics to you wherever you are. Thanks for listening, and don't forget to follow and rate us in your podcast app. Yeah, thanks for joining us everyone.
0:29So, imagine for a 2nd that you're going to the doctor because you've been dealing with like a truly baffling combination of symptoms. Right, the kind that just don't seem to fit together at all. Exactly.
0:40You've got chronic gastrointestinal issues, your joints are, you know, unusually flexible, maybe prone to pain. And then on top of that, your heart just suddenly starts racing the 2nd you stand up from a chair.
0:52It's a lot to deal with. It really is. And in the current medical system, You might get sent to 3 completely different specialists, right? Oh, absolutely. And you might walk away with 3 separate, seemingly unrelated diagnoses.
1:04Right. Like a gastroenterologist tells you it's IBS, a rheumatologist says, uh, maybe Ehlers Danlas syndrome? And the cardiologist diagnoses POTS or postural orthostatic tachycardio syndrome? Exactly. So you're handed 3 different treatment plans for what look like 3 distinct problems.
1:22But what if they aren't actually different problems? Right. What if a single hidden genetic quirk was actually connecting them all? That is the $1000000 question. Because today we are doing a deep dive into this, like, invisible genetic modifier that actually affects roughly one in 20 people.
1:41Yeah, that's 4 to 6% of the general population. Which is huge. But it routinely goes completely undiagnosed. Today we celebrate the work of the research team at the University Medical Center, Groningen, and the University of Groningen in the Netherlands, who have advanced our understanding of hereditary alpha tryptocemia diagnostics.
2:01Yeah, it's really incredible work. But so right out of the gate. I mean, how does a genetic condition that affects up to 6% of the population remain so hidden from routine clinical diagnostics? Well, to understand that blind spot, we really have to look at the underlying biology.
2:17Okay. Specifically we need to talk about mast cells. They are essentially the immune system's 1st responders, you know. Right. Right. So they're like out on patrol. Exactly. They hang out in tissues that interface with the outside world.
2:31So your skin, your respiratory tract, your gut. And they're packed with these little granules full of potent chemicals, just ready to be released during an allergic reaction or an inflammatory response.
2:44Gotcha. And one of the main chemicals in those granules is this enzyme called trip taste, right? It's spot on. It's a primary enzyme stored right there in the mass cells. Okay, so let's focus on that enzyme for a second, because I want to bridge the gap between immune cells and those mechanical issues we mentioned, like flexible joints or a racing heart.
3:03Right. Clinical symptoms. Yeah. How does an immune enzyme lead to all of that? Well, it comes down to what Triptase actually does when it's released into the tissues. Okay, what does it do? It's a protease.
3:14So its job is to break down proteins. And it's really heavily involved in homeostatic processes. Meaning, like, keeping things balanced. Yeah, keeping your airway, your blood vessels, and your gastrointestinal smooth muscles functioning normally.
3:27Right. But when there's chronically too much trip taste, just sort of seeping into the surrounding tissues, it starts to subtly alter the extracellular matrix. Which is like the structural scaffolding of the body.
3:39Exactly. And it can also affect vascular smooth muscle tone. Oh, I see. Okay, let's unpack this. Because if your vascular tone is altered and your blood vessels are like overly relaxed, then gravity is going to pull your blood downward when you stand.
3:53Which is exactly what happens. And then your heart has to rapidly accelerate to pump that blood back up to your brain. Yes, and that rapid acceleration is what manifests clinically as POTS. Wow. And I'm guessing those subtle changes to the connective tissue matrix lead to the joint hypermobility and pain we associate with Eller Stanless.
4:12Exactly right. The overproduction of triptase alters the baseline functioning of these systems. is wild. It is. And that brings us to the focus of this research, which is a condition called hereditary alpha tryptocemia, or HLT.
4:25Alpha T, okay. Yeah. It's an autosomal, dominant genetic condition caused by simply having extra copies of the alpha tryptase gene. Right, an autosomal dominant, meaning you only need to inherit the extra copy from one parent to express the trade.
4:38Exactly. But having extra copies of a gene doesn't always result in, you know, an actual pathology. So what is the actual clinical burden for someone walking around with H Alpha T? Well, it essentially acts as a massive clinical amplifier.
4:52It's a hidden modifier of other diseases. Not a fire, okay. Right. So like we discussed, it can mimic IBS or POTS. But the true danger really emerges when H alpha T intersects with other primary mass cell disorders.
5:06Like what? Well, consider a patient with a rare condition called systemic mastocytosis or SM. Okay. In SM, the body just naturally produces an abnormally high number of mass cells. Oh, so they already have too many of those 1st responder cells.
5:19Right. Now factor in an environmental trigger, like an allergy to wasp stinks. Okay, so you have way too many mast cells, and then you encounter a severe allergen. Exactly. And if that patient also happens to have H alpha T, their risk of experiencing fatal anphhylaxis from that wasp sting drastically increases.
5:35Wait, really? Just because of the extra gene copies? Yes, the extra copies of the alpha tryptase gene modify and amplify the severity of the reaction. The baseline genetic code is acting like a multiplier.
5:48Wow, that changes the whole paradigm. I mean, it means the wasp sting isn't the primary danger. just the trigger. The patient's baseline genetic code is acting like a loaded gun. That's great way to put it.
5:59So if it's this critical, I mean, if it's amplifying severe reactions, why is it such a nightmare to actually diagnose? Yeah, that's the real problem. Like if I go to my doctor and ask for a genetic test, why can't they just, you know, run my DNA and count the genes?
6:13Well, the difficulty lies entirely in the architecture of the genetic neighborhood where this gene lives. The neighborhood. Yeah. The human trip taste locust is located on chromosome 16. Okay. And the relevant genes here are TPSAV one, which encodes either alpha or beta trip days. Right. And TPSB two, which only encodes beta trip days.
6:32Got it. So TPSAB one is alpha or beta, and TPSB 2 is just beta. Exactly. But the problem for geneticists is that this entire region of the genome is highly repetitive. How repetitive are we talking? Extremely.
6:44The beta trip taste sequences are 98 to 99% identical to each other. Wow. And the alpha sequences are about 93% identical to the beta sequences. Oh man. Okay let's unpack this. Doing standard, like, short read genetic sequencing on this region has to be essentially like trying to read a massive book where consecutive pages are 98% identical.
7:08That's exactly what it's like. You're going to constantly lose your place. The sequencing machines certainly do. I mean, a standard machine reads short fragments of DNA and tries to stitch them together based on overlapping patterns.
7:19But when the sequences are nearly identical repeats, the machine just gets confused. It can't determine if it's reading a new copy of the gene or if it's just rereading the exact same copy. just looked at.
7:29So the whole linear sequence just collapses into an ambiguous blur. Precisely. Okay, so if standard genomic sequence and gets lost in the repetitive pages. How can doctors actually measure this to help you?
7:41I mean, we have 1000000s of patients looking for answers, and our primary genetic reading tools are basically useless here. Right. Well, the conceptual breakthrough is that you have to stop trying to, you know, read the genetic sequence linearly.
7:56Instead, you have to start physically counting the individual pieces. Oh, counting. Yeah, and that shift in strategy is really the core methodology of this deep dive. So how do they count them? Well, historically, the gold standard for diagnosing age alpha T was this highly complex double well digital droplet PCR asset.
8:15Double well digital droplet PCR. It worked, but it was really cumbersome. So the research team in the Netherlands set out to streamline this by developing a highly efficient single well multiplex digital droplet PCR essay.
8:28Single well. And we call this Diddy PCR for sure, right? Right, exactly. Okay, let's break down that technology for the listener, because digital droplet PCR is vastly different from the traditional PCR most people might be familiar with.
8:40Yeah, it really is a different beast. How does a single well multiplex DDPCR actually work in practice? So the fundamental difference is partitioning. In traditional PCR, you amplify DNA in one bulk solution, right?
8:55Right, like one big test tube. Yeah, and you estimate the starting amount based on how quickly the target amplifies. It's an estimation. Okay. But in digital droplet PCR, the process becomes absolute. How so?
9:07First, you extract DNA from a patient's blood or bone marrow. It has to be high quality. And it's carefully diluted to an optimal concentration of exactly 15 anagrams per milliliter. Exactly 50. Okay. Then the sample is forced through a microscopic fluidic channel where it intersects with an oil mixture.
9:24Wait, oil? Why oil? Because that partitions the sample into thousands of microscopic water and oil droplets. Oh, wow. So you are separating the diluted DNA fragments into roughly 20,000 tiny independent compartments.
9:38Basically 20,000 independent test tubes, yeah. That's incred. And inside those droplets. The researchers play specific fluorescent probes. They use a chemical dye called HEX, which is engineered to glow only when it binds to the alpha variant.
9:52Okay, HEX for alpha. Right. And they use another die called FAM, which glows only when it binds to the beta variant. But wait, earlier you mentioned that the alpha and beta sequences are 93% identical.
10:04Yes they are. If they are that similar, how does the machine tell them apart once they're in the droplets? Well, the researchers design the HEX and fan probes to target the specific nucleotide differences.
10:16You know, that 7% variation that actually distinguishes alpha from beta. Oh, clever. So the probes just ignore the identical regions and latch onto the unique identifier. Exactly. Okay, so if I'm picturing this, it's like we have all these different colored beads, the jeans strung together on a necklace.
10:31Okay, I like that analogy. And the DDPCR is basically a machine that sorts those individual beads into 1000s of tiny cups. Then we just shine a light on the cups and count how many glow with the HEX color for alpha and how many glow with the fam color for beta.
10:45That is the core mechanism. Yes. But it requires a really critical preparatory step. What's that? Well, before partitioning the DNA into the droplets, the researchers used a specific restriction enzyme called Bam High.
10:58Bam I. Right. And they used it to literally digest or chop up the DNA into pieces. Whoa, wait a minute. But isn't chopping up the DNA risky? How do we know we aren't destroying the very sequence we are trying to measure?
11:12I mean, taking biochemical scissors to the sample feels counterproductive. I know it sounds that way, but what's fascinating here is that digesting the DNA actually corrects a massive potential measurement error.
11:24Really? How? Well, you're destroying the broader chromosomal context, sure, but you are isolating the functional units. It prevents the system from underestimating the number of alpha copies. Why would it underestimate them?
11:36Because in patients with hereditary alpha triptocemia, The extra alpha Triptase copies often sit directly next to each other on the same chromosome. We call this being cis formatted. Oh. I say the physical problem.
11:48If I have a necklace where 2 blue beads are glued tightly together, and I toss them into a sorting cup, without cutting the string between them, they go into the exact same cup. Exactly. And because they're in the same droplet.
12:00They would emit a single, slightly brighter fluorescent signal. So the optical reader would look at that droplet, see the HEX die glowing, and record it as a single positive event. It would count one alpha copy, completely missing the fact that there were actually 2 copies physically linked inside that droplet.
12:19Wow. So the Bamichai restriction enzyme is the solution to that. Yes, it acts as those microscopic scissors you mentioned. It recognizes these specific sequences flanking the genes and cuts the DNA string just outside the targets.
12:32That is brilliant. By severing the physical connection between those tandem gene copies, Bamai ensures that every individual copy floats freely. Which virtually guarantees that each gene gets sorted into its own separate troplet.
12:45Right. So it transitions this from just an estimation to absolute precise quantification. You're no longer guessing based on signal strength. You're getting an exact discrete count of the alpha and beta genes.
12:57Okay, so the methodology makes a lot of sense. Building a high-tech droplet sorter with biochemical scissors is brilliant in theory. But biological samples are notoriously messy. Oh very messy. So how did this new single well assay actually perform when they moved it from theoretical validation to real patients with unexplained symptoms?
13:21Well, the laboratory performance data was incredibly robust. They have validated the assay on a clinical cohort of 281 cases. That's a solid number Yeah. And they evaluated the accuracy of determining the copy number variants, which is obviously the ultimate goal.
13:36The overall accuracy was calculated at .03 plus or minus .27 copy numbers. Wow. And that's at a 99% prediction interval. Let's translate those statistics into clinical reality. A Bureau .03 margin of error at a 99% prediction interval basically means the margin of error is clinically non-existent.
13:55Exactly. highly, highly accurate. So for a lab tech running this test, the machine isn't returning a report saying, oh, this patient might have 2 or 3 copies. No, it is definitively saying this patient has exactly 3 copies.
14:07The precision removes all the diagnostic muddy waters. It really does. Yeah. But the research team didn't stop at merely validating the genetic counting mechanism. Oh, what else do they do? They needed to prove that what they were counting in the DNA actually mapped to what was happening physically in the body.
14:24Right, connecting the genetics to the symptoms. Yeah, so to do this, they isolated a subset of 141 highly symptomatic patients from the larger cohort. Okay. And they had to be careful with that cohort, right?
14:37Because if you're trying to prove a direct link between a gene and a protein level, you have to remove any other biological noise that might artificially inflate those protein levels. Oh they were meticulous about that.
14:48They completely ruled out any patients in the subset who had other known causes for elevated triptase. Like what? Well, for instance, they excluded patients with end stage renal failure. Because if your kidneys are failing, they can't clear tryptase from the blood, which leads to an artificial elevation.
15:06They also excluded primary systemic mastocytosis. They only looked at people where the elevated baseline triptase was an unexplained mystery. Okay, so you have this really pure cohort of symptomatic patience.
15:19You have their exact genetic droplet counts. And you draw their blood to measure the actual amount of trick taste proteins floating in their system. Right. What did they find when they overlaid those 2 data sets?
15:31They documented a stunning gene dose relationship? Really? Yeah, they discovered that for every single extra alpha tryptaste copy a patient inherits, their basal serum tryptaste level or BST increases by an average of exactly 7.5 nanagrams per milliliter.
15:48Here's where it gets really interesting. In human biology, systems are almost never that clean. No, they really are. Biology is inherently messy. There are usually a dozen interacting variables, feedback loops, epigenetic factors altering protein expression.
16:01Exactly. To see a perfectly linear, predictable mathematical relationship, where one extra genetic copy equals exactly 7.5 nanograms per milliliter of protein in the blood. is rare. It is a remarkable demonstration of direct causality in human genetics.
16:16The physical presence of the gene directly and predictably drives the physiological dosage of the enzyme. So if the blood levels match the genetics so perfectly, Is there a magic number in a basic blood test that tells a doctor to look for H alpha tea?
16:31I mean, do they even need to start with a complex droplet PCR? That's the beauty of it. Yes, there is a magic number. through their statistical analysis of the cohort. They established that a BST cutoff of 9.2 nanagrams per milliliter is highly predictive.
16:489.2, okay. Yeah. If a symptomatic patient presents with a serum tryptase level of 9.2 or higher, it predicts the presence of hereditary alpha tryptocemia with 98.one% sensitivity and 96.6% specificity.
17:01That is massive for routine clinical practice. It really is. If you come in with chronic gastro issues or hypermobility, a general practitioner doesn't need to order specialized genomics immediately. Right, they don't have to.
17:12They can just run a standard, inexpensive blood test for basal serum trip taste. And if it comes back at 10 or 12 nanagrams per milliliter, It is a giant flashing light saying, run the droplet PCR. This patient likely has a hidden genetic modifier.
17:28Exactly. And we connect this to the bigger picture. That workflow is exactly the paradigm shift this paper represents. It's a huge shift. It is. This single well multiplex DVPCR assay isn't just some interesting laboratory experiment designed for research.
17:43It is ready to be implemented right now as a state-of-the-art routine diagnostic test. And to facilitate that global implementation, the researchers took one more crucial step. They establish standardized reference controls.
17:56Oh, right, because clinical diagnostics require consistency. If a lab in Tokyo and a lab in Toronto, both by the equipment to run this droplet assay, they need a way to prove their machines are calibrated to read the droplets identically.
18:08Exactly. So they characterize 2 specific immortalized cell lines to serve as global benchmarks. They use the HMC one. cell line, which naturally has 0 Alpha Triptais copies, to act as a perfect negative control.
18:22Smart. And for the positive control. They utilize the Monomax 6 cell line, which is proven to carry an alpha duplication. Oh, so any diagnostic lab can run these standardized cells alongside a human patient sample.
18:35Right. And if the machine reads 0 alphas for the negative control and shows the duplication for the positive control, the technician knows with absolute certainty that the assay is accurately sorting and counting the genetic droplets for the patient.
18:49It creates a universal standard for diagnostic accuracy. So what does this all mean? We have a new, highly accurate asset. It is backed up by beautiful linear mathematics linking the genetics to the blood work.
19:00It has standardized global controls. But let's get a reality check. Is this essay completely flawless? Or does it have blind spots that doctors need to watch out for? Well, it is a massive technological leap forward.
19:12But, you know, it does have specific limitations. Practically speaking, it requires a minimum input of 10 nanagrams of high quality DNA to achieve reliable droplet saturation. So you can't run this on highly degraded samples.
19:26No, you can't. But the more profound limitation involves structural overlap. What you mean? While the assay is brilliant accounting the total number of alpha and beta copies in a sample, it cannot definitively tell you how those copies are distributed across the 2 chromosomes.
19:41Wait, if it just counts the total number of glowing beads in the cups, how does it know which side of the family they came from? Let's say the final droplet count shows a patient has a total ratio of 2 beta copies and 4 alpha copies.
19:55The machine just sees 6 total units. And that is the structural puzzle. That 2 beta 4 alpha ratio definitively diagnoses the patient with H alpha T. But genetically, there are two distinct ways to arrive at that final count.
20:09Okay, how so? A patient could have a double duplication on one allele, meaning one chromosome holds one beta and three alphas, while the other chromosome is perfectly normal. Got it. Alternatively, a patient could have a triplication on one allele and a normal gene on the other.
20:24Both spatial arrangements yield the exact same total bead count in the droplets. Oh, I see. But does that chromosomal distribution actually matter for treating the patient? I mean, if the total amount of triptase in the blood is driving the symptoms, does the physical arrangement on the chromosome change the medical management?
20:42For routine clinical care, it largely doesn't matter. Okay, good. The total genetic load is what drives the baseline serum trip tastes. And the serum tripase drives the severity of the symptoms. So knowing the absolute total count is sufficient for managing a patient's condition.
20:58However, in rare ambiguous cases where knowing the exact chromosomal distribution is necessary, such as complex family planning or highly specialized genetic research, this assay hits a wall. So what do you do then?
21:11In those cases, parental genotyping might be required. Ah. Yeah. By testing the parents, you can trace exactly how the clusters of copies were inherited and solved the spatial arrangement. That makes total sense.
21:21Okay, let's pull all of these threads together. By developing a highly precise single well, digital droplet PCR assay. Researchers have unlocked a reliable way to diagnose hereditary alpha tryptocemia.
21:34They really have. They utilized a restriction enzyme to isolate individual gene copies, allowing them to decode a highly complex repetitive genetic region. And furthermore, they prove that this genetic quark isn't just background noise, right?
21:48Every extra alpha tryptaste gene directly drives up serum tryptaste levels by exactly 7.5 nanagrams per milliliter, providing a clear biological mechanism for a host of syndromeic symptoms. What does this mean for the 1000s of patients currently navigating the medical system with a patchwork of generic systemic diagnoses who might finally be one highly accurate droplet test away from a clear genetic answer?
22:11This episode was based on an open access article under the CCBY 4.0 license. You can find a direct link to the paper and the license in our episode description. If you enjoyed this, follow or subscribe in your podcast app and leave a 5 star rating.
22:25If you'd like to support our work, use the donation link in the description. Now stay with us for an original track created especially for this episode and inspired by the article you've just heard about.
22:35Thanks for listening and join us next time as we explore more science base by base. White code at midnight. Quiet lab heat, a tiny storm and drop its keep time with the beat. I'm chasing a number that won't sit still in the hush of a sample.
23:15A stubborn thrill. Cut the DNA clean, let the pieces fall. Count every signal like a roll call. If the clusters don't blur, the truth comes through. One well, one red, no guess work to do. If it's 9.2 Let it rain true.
23:31A line in the blood says what jeans might do. Extra alpha copies turning up the plane. Those by those, they call your name. If it's 9.2 We finally see. What was hiding in plain biology. Lightning, but the sky looks clear.
24:02symptoms and the daylight answers disappear. Now the copy numbers snap into view. Alpha and Beta, in a motor, Plex Groove, then the baseline rises, Steady and straight, like footsteps, climbing toward the gate.
24:24Not every pattern tells you where it lies. Some shadows share the same disguise. But give me good DNA, a careful start, and the droplets match the beating heart. From down to detail. From noise to proof.
24:45We pull the signal up through the roof. If it's 9.2 Let it rain true. A line in the blood says what jeans might do. Extra alpha copies turning up the plane. Go spy dose, they call your name. If it's 9.2 We don't just cope.
25:08We draw a clean path from ache to hope. One with one light. Breaking through. If it's 9.2.
